Valsamaki PN - Search Results

1

The Emerging Role of the Gut Microbiome in Cardiovascular Disease: Current Knowledge and Perspectives.

Papadopoulos PD, Tsigalou C, Valsamaki PN, Konstantinidis TG, Voidarou C, Bezirtzoglou E. Papadopoulos PD, et al. Among authors: valsamaki pn. Biomedicines. 2022 Apr 20;10(5):948. doi: 10.3390/biomedicines10050948. Biomedicines. 2022. PMID: 35625685 Free PMC article. Review.

2

[Cutaneous malignant melanoma; diagnostic procedures and their evaluation in diagnosing and mapping sentinel nodes].

Valsamaki P, Zanglis A, Gerali S. Valsamaki P, et al. Hell J Nucl Med. 2009 Sep-Dec;12(3):296-303. Hell J Nucl Med. 2009. PMID: 19936352 Review. Greek, Modern.

3

Cardiac amyloidosis. Two main subtypes and diagnosis by Nuclear Medicine: SPET tracer revival.

Valsamaki PN, Zissimopoulos A. Valsamaki PN, et al. Hell J Nucl Med. 2019 Sep-Dec;22(3):161-164. doi: 10.1967/s002449911050. Epub 2019 Oct 7. Hell J Nucl Med. 2019. PMID: 31587024 Free article. No abstract available.

4

[Cutaneous melanoma; diagnostic procedures and their evaluation in diagnosing and mapping sentinel nodes. Part 2].

Valsamaki P, Zanglis A, Chatzipetrou A. Valsamaki P, et al. Hell J Nucl Med. 2010 May-Aug;13(2):191-6. Hell J Nucl Med. 2010. PMID: 20809001 Review. Greek, Modern.

5

[A patient with MEN-IIA syndrome due to de novo mutation and papillary thyroid carcinoma; the role of 99m Tc-depreotide in diagnosing metastases and brief review of the literature].

Valsamaki P, Gerali S, Arka A, Kotsias D, Lucchetti S, Psarrakos K, Zerva C, Gotzamani-Psarrakou A. Valsamaki P, et al. Hell J Nucl Med. 2004 Sep-Dec;7(3):168-73. Hell J Nucl Med. 2004. PMID: 15841292 Greek, Modern.

6

Tc-99m depreotide imaging of I-131-negative recurrent metastatic papillary thyroid carcinoma.

Valsamaki P, Gotzamani-Psarrakou A, Tsiouris S, Molyvda-Athanasopoulou E, Psarrakos K, Papantoniou V, Gerali S, Zerva C. Valsamaki P, et al. Int J Cancer. 2006 Aug 15;119(4):968-70. doi: 10.1002/ijc.21930. Int J Cancer. 2006. PMID: 16550594 Free article.

7

[Lymphatic system and lymphoscintigraphy].

Valsamaki P. Valsamaki P. Hell J Nucl Med. 2009 Jan-Apr;12(1):87-9. Hell J Nucl Med. 2009. PMID: 19330197 Greek, Modern.

8

Technetium-99m labelled red blood cells scintigraphy and not iminodiacetic acid cholescintigraphy facilitates the discrimination of hepatic cirrhosis from fibrosis.

Papantoniou V, Valsamaki P, Skorda L, Papantoniou I, Delichas Z, Zacharakis G, Michopoulos S, Dimopoulos M, Koskinas I. Papantoniou V, et al. Hell J Nucl Med. 2015 Sep-Dec;18(3):238-42. doi: 10.1967/s002449910306. Epub 2015 Nov 18. Hell J Nucl Med. 2015. PMID: 26574694

9

Towards the optimization of nuclear medicine procedures for better spatial resolution, sensitivity, scan image quality and quantitation measurements by using a new Monte Carlo model featuring PET imaging.

Karpetas GE, Michail CM, Fountos GP, Valsamaki PN, Kandarakis IS, Panayiotakis GS. Karpetas GE, et al. Among authors: valsamaki pn. Hell J Nucl Med. 2013 May-Aug;16(2):111-20. doi: 10.1967/s002449910082. Epub 2013 May 20. Hell J Nucl Med. 2013. PMID: 23687642

10

Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy.

Papantoniou V, Valsamaki P, Kastritis S, Tsiouris S, Delichas Z, Papantoniou Y, Tsiouma M, Athanasoulis T, Fotopoulos A, Dimopoulos MA. Papantoniou V, et al. Hell J Nucl Med. 2015 Sep-Dec;18 Suppl 1:42-50. Hell J Nucl Med. 2015. PMID: 26665211

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page